The Effect of Mobilization on Inflammatory Biomarkers in Patients With Knee Osteoarthritis.
The Effect of Mobilization With Movement Versus Sham Mobilization on Inflammatory Biomarkers in Patients With Knee Osteoarthritis.
1 other identifier
interventional
40
1 country
1
Brief Summary
This study is designed to investigate whether a hands-on therapy called Mobilization with Movement (MWM) can reduce pain and inflammation in individuals with knee osteoarthritis (OA). The investigators will compare MWM to a sham treatment that resembles mobilization but does not involve the specific therapeutic movements. Both groups will also receive standard care, including exercise and education about managing knee OA. A total of 40 adults (aged 18 years and older) with moderate to severe knee OA will be enrolled. Participants will be randomly assigned to either the MWM group or the sham group. Each intervention will be delivered twice per week over a four-week period. Outcomes will include measures of inflammation obtained from blood samples, self-reported pain levels, and assessments of knee function before and after the intervention period. It is hypothesized that individuals allocated to the MWM group will demonstrate reduced inflammation and pain compared with those in the sham group. The findings of this study may help clarify the potential role of MWM as a treatment option for knee OA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable knee-osteoarthritis
Started Sep 2025
Shorter than P25 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2024
CompletedFirst Posted
Study publicly available on registry
September 10, 2025
CompletedStudy Start
First participant enrolled
September 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2026
CompletedDecember 9, 2025
December 1, 2025
5 months
November 28, 2024
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
C-Reactive Protein (CRP)
CRP levels will be measured in unit of measure (mg/L) using a high-sensitivity assay.
Baseline and 4 weeks post-intervention.
Erythrocyte Sedimentation Rate (ESR)
ESR will be measured in mm/hr using the Westergren method.
Baseline and 4 weeks post-intervention.
Secondary Outcomes (2)
Pain Intensity
The outcome measure will be assessed at the baseline and 4 weeks post-intervention.
Functional Status
The outcome measure will be assessed at the baseline and 4 weeks post-intervention.
Study Arms (2)
Intervention Group
EXPERIMENTALThe intervention group will receive mobilization with movement for the affected knee with standard care (exercise program to strengthen the musculature of the knee).
Control Group
PLACEBO COMPARATORThe control group will receive sham mobilization with movement for the affected knee with standard care (exercise program to strengthen the musculature of the knee).
Interventions
standard care (exercise program to strengthen the musculature of the knee)
The therapist will simulate MWM by performing slight external rotation of the skin only. This mimics the tactile sensation of true MWM without affecting the underlying joint mechanics.
A continuous glide to the tibia will be a combined simultaneously by whether medial, lateral, anterior, posterior, or rotational-during active knee flexion and extension repeated movement as applied by Mulligan.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of unilateral or bilateral knee osteoarthritis (OA) according to the criteria of the American College of Rheumatology
- Age ≥ 18 years
- Kellgren-Lawrence grade 2 or 3 knee OA
- Pain intensity \> 3 on a visual analogue scale (VAS)
- Body mass index (BMI) between 18.5 and 30 kg/m²
You may not qualify if:
- Knee or lower limb surgery within the last six months.
- Significant joint disorders (e.g., rheumatoid arthritis, gout, or other inflammatory arthritis).
- Recent significant acute infections.
- Contraindications to mobilization with movement.
- Current or recent use systemic glucocorticoids, intra-articular glucocorticoid injections or intra-articular hyaluronic acid injections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jazan University Hospital
Jizan, Jazan Region, 82722, Saudi Arabia
Related Publications (6)
Li LL, Hu XJ, Di YH, Jiao W. Effectiveness of Maitland and Mulligan mobilization methods for adults with knee osteoarthritis: A systematic review and meta-analysis. World J Clin Cases. 2022 Jan 21;10(3):954-965. doi: 10.12998/wjcc.v10.i3.954.
PMID: 35127909BACKGROUNDShabbir M, Gul I, Asghar E, Muhammad N, Mehjabeen H, Rafiq I, Arshad N. Effectiveness Of Maitland's Mobilization And Conventional Physical Therapy On Synovial Biomarkers In Patients With Knee Osteoarthritis; A Randomized Control Trial. Webology. 2022 Apr 1;19(2)
BACKGROUNDHanada M, Takahashi M, Furuhashi H, Koyama H, Matsuyama Y. Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity. Ann Clin Biochem. 2016 Sep;53(Pt 5):548-53. doi: 10.1177/0004563215610142. Epub 2015 Sep 17.
PMID: 26384360BACKGROUNDZaki NA, Saleem TH, Said E, Hassan MH. Evidence of contributory role of inflammation in patients with knee osteoarthritis. SVU-International Journal of Medical Sciences. 2020 Jan 1;3(1):1-6.
BACKGROUNDAlthomali OW, Amin J, Acar T, Shahanawaz S, Talal Abdulrahman A, Alnagar DK, Almeshari M, Alzamil Y, Althomali K, Alshoweir N, Althomali O, Aldhahi MI, Bin Sheeha BH. Prevalence of Symptomatic Knee Osteoarthritis in Saudi Arabia and Associated Modifiable and Non-Modifiable Risk Factors: A Population-Based Cross-Sectional Study. Healthcare (Basel). 2023 Mar 2;11(5):728. doi: 10.3390/healthcare11050728.
PMID: 36900733BACKGROUNDCui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020 Nov 26;29-30:100587. doi: 10.1016/j.eclinm.2020.100587. eCollection 2020 Dec.
PMID: 34505846BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- While participants and outcome assessors are blinded to treatment allocation, therapists delivering the MWM and sham mobilization interventions are aware of the assigned treatment for each participant. However, therapists are blinded to all outcome measures, including pain scores, inflammatory marker results, and functional assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer, Department of Physical Therapy, Principal Investigator
Study Record Dates
First Submitted
November 28, 2024
First Posted
September 10, 2025
Study Start
September 20, 2025
Primary Completion
February 20, 2026
Study Completion
April 20, 2026
Last Updated
December 9, 2025
Record last verified: 2025-12